BD Biosciences is a world leader in bringing innovative diagnostic and research tools to life scientists, laboratory professionals and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.
With a corporate philosophy of "Helping all people live healthy lives", this segment of BD has a focus on continually advancing the science and applications associated with cellular analysis. Continuing a legacy of innovation and technological excellence, BD Biosciences develops and supplies flow cytometry instrumentation, software, and reagents for cell isolation and analysis – both for research use and clinical diagnosis.
Additionally, they offer a selection of services around cell analysis and custom reagents to support drug development programs, and provide support in the form of in-depth knowledge and experience that comes from over 25 years of working with customers to develop these tools and to improve workflow, ease-of-use, and performance.
Since commercialising the first cell sorter in 1973, BD Biosciences has continued to develop flow cytometry systems that are more powerful and more dependable. Today’s high-speed research flow cytometers include cell analysers and cell sorters, and range from easy-to-use benchtop systems to special order systems that can be configured to fit precise research and assay needs.
Flow cytometry allows analysis of multiple parameters simultaneously in biological/cellular samples. BD’s development of instrumentation capable of detecting more parameters (more different fluorescent probes) at a time enables users to obtain more information per volume of sample, on a cell-by-cell basis. This ability to "multiplex", together with options for higher sample throughput and automation all factor in to increase throughput of this technology.
To address the need for increased data integrity, one of BD’s newest research analysis systems, the BD FACSVerse, is 21 CFR Part 11 compliant.
BD Biosciences research cell sorters offer dependable, high performance cell isolation, with unique advantages of being able to isolate specific subsets and even rare subpopulations with very high purity. They also offer solutions for biosafety considerations. BD cell sorters support single-cell isolation, which can be useful for later downstream applications, such as cell cloning, next-gen sequencing, or other analysis.
Flow cytometry-based assays offer high-content, single-cell data that can be useful in drug discovery. BD develops ready-to-use kits and reagents for advanced cell- and particle-based assays that can be used to explore cellular features and characterise cells through surface, intracellular, or secreted markers.
The antibody selection is extensive, and includes a kit that has several hundred different markers for cell surface protein expression screening. Antibodies and reagents conjugated to a wide choice of fluorochromes gives users more choice when combining parameters, enabling them to get more data per assay and per sample.
BD Biosciences clinical solutions include flow cytometry cell analysers, reagents, and software that help clinicians diagnose and improve patient care. The solutions are designed to simplify analysis and workflow while maintaining a high standard of reliability and consistency of results